BC Platforms (BCP), a global leader in healthcare data processing, analytics, and access, has announced a new strategic alliance with TripleBlind, a US-based organization, to help accelerate the advancement of privacy and intellectual property rights (IPR) for its BCRQUEST.com Global Data Partner Network.
BCP’s contribution to the Finnish-led PRIVASA (Privacy-Preserving AI for Synthetic and Anonymous Health Data) consortium recently secured EUR €6.5 million in funding from Business Finland to improve mechanisms for the secure use of confidential data, will be enhanced as a result of the collaboration.
The PRIVASA initiative, which wills last two years, seeks to increase access to and dissemination of anonymized health data in order to help Finnish health technology businesses compete in foreign markets.
BCP will contribute federated AI learning methods that will enable machine learning algorithms to be trained without the need for actual data to be exchanged. Individual-level data would never need to abandon its institution of origin, allowing BCP to meet data governance and privacy criteria. BCP’s collaboration with TripleBlind will strengthen this federated AI definition by maintaining IPR security and encrypting analyses and data with its own cryptographic technologies.
“In collaboration with TripleBlind, our new federated AI learning model, which is built on data from BCRQUEST’s global genomic and clinical information network, could greatly speed up research and development without violating patient privacy or IPR,” said Timo Kanninen, CSO and Founder of BC Platforms. AI has the ability to turn healthcare from a “one-size-fits-all” to a “personalized” model, in which customized treatment options will be adapted for each patient, resulting in better care and substantial cost savings.”
“We are delighted to be working with BCP, combining our next-generation private data exchange infrastructure with BCRQUEST’s data network for use in testing environments with stringent regulatory requirements such as GDPR, CCPA, and HIPAA,” said Riddhiman Das, CEO, and Co-Founder of TripleBlind. We’re excited to provide the network the ability to exchange and communicate with huge amounts of data that are still un-accessible and uncommercialized due to regulatory concerns. We would be able to use richer, more diverse third-party clinical and genomic databases as a result of improved anonymity, allowing for the advancement of more reliable and less skewed novel AI-based models.”
Along with the University of Turku, the Finnish Institute for Health and Welfare (THL), and a host of prominent business members such as Bayer, Fujitsu Finland, MVision, PerkinElmer, and Polar Electro, BC Platforms is a core corporate participant in the PRIVASA consortium.